Dr. Dhaval Shah, MD (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Tempe, AZ with over 14 years of experience. What is your opinion of Dr. Dhaval Shah, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 14 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Dhaval Shah, MD has received over $9,073 which includes payments from the following companies:
$2,303.31 from Edwards Lifesciences Corporation
$709.96 from AstraZeneca Pharmaceuticals LP
$674.18 from Medtronic Vascular, Inc.
$612.29 from Janssen Pharmaceuticals, Inc
$554.30 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$541.78 from Astellas Pharma US Inc
$496.85 from Boehringer Ingelheim Pharmaceuticals, Inc.
$484.58 from Otsuka America Pharmaceutical, Inc.
$454.05 from Pfizer Inc.
$385.80 from Daiichi Sankyo Inc.
$260.82 from Novartis Pharmaceuticals Corporation
$235.72 from Lantheus Medical Imaging, Inc.
$230.44 from Boston Scientific Corporation
$227.46 from sanofi-aventis U.S. LLC
$142.01 from E.R. Squibb & Sons, L.L.C.
$140.49 from Amgen Inc.
$104.89 from LILLY USA, LLC
$98.14 from Merck Sharp & Dohme Corporation
$59.28 from Biosense Webster, Inc.
$42.30 from Relypsa, Inc.
Payments received by Dr. Dhaval Shah, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!